Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

Did you know that a small molecule called NAD+ plays a critical role in our aging process? A deficiency of this molecule may ...

In 1954, the world's first successful organ transplant took place at Brigham and Women's Hospital, in the form of a kidney donated from one twin to the other. At the time, a group of doctors and ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

A review of randomized clinical trials published in rheumatology from 2009 to 2023 found that just 39.8% of authors were women, and that women were less likely to be senior authors, according to data ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

FDA's plan to phase out animal testing may hurt Charles River's revenues. The DCF model suggests that CRL presents an ...

Cardiovascular disease (CVD) ranks as a primary driver of morbidity and mortality globally, pushing the boundaries of health care management and ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.

Nucleic acid immunity involves a sophisticated set of mechanisms for identifying nucleic acids by immune receptors, playing a vital role in physiological ...

The initial implementation phase of myUABResearch, the university’s new electronic research administration system, is on ...